Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does lipitor affect avocado growth?How does dietary fat influence lipitor's effectiveness?What checks are necessary for lurbinectedin's long term use?Does patient health influence nivolumab's optimal treatment duration?Did the fda grant approval to lurbinectedin for treating ovarian cancer?
See the DrugPatentWatch profile for sapropterin
How did symptoms occur with sapropterin in clinical trials? In clinical trials, adverse events were reported by 75% of patients taking sapropterin and 71% of patients taking placebos. The events reported were mostly mild to moderate. Mild to moderate headaches occurred in 10% of sapropterin patients and 9% of placebo patients. Mild to moderate rhinorrhea occurred in 7% of sapropterin patients and 6% of placebo patients. Mild to moderate pharyngolaryngeal pain occurred in 6% of sapropterin trials and 5% of placebo patients. Mild to moderate diarrhea occurred in 4% of sapropterin patients and 3% of placebo rates. How does sapropterin compared with placebo rates? The events reported were mostly mild to moderate. Mild to moderate headaches occurred in 10% of sapropterin patients and 9% of placebo patients. Mild to moderate rhinorrhea occurred in 7% of sapropterin patients and 6% of placebo patients. Mild to moderate pharyngolaryngeal pain occurred in 6% of sapropterin trials and 5% of placebo patients. Mild to moderate diarrhea occurred in 4% of sapropterin patients and 3% of placebo rates. When did symptoms occur with sapropterin? In clinical trials, adverse events were reported by 75% of patients taking sapropterin and 71% of patients taking placebos. The events reported were mostly mild to moderate. Mild to moderate headaches occurred in 10% of sapropterin patients and 9% of placebo patients. The events reported were mostly mild to moderate. Mild to moderate rhinorrhea occurred in 7% of sapropterin patients and 6% of patients on placebos. Mild to moderate pharyngolaryngeal pain occurred in 6% of sapropterin patients and 5% of placebo patients.
Other Questions About Sapropterin :